Navigation Links
7.0mm Trephine Handle

Products7.0mm Trephine Handle
Company Medtronic Xomed, Inc.
Item 7.0mm Trephine Handle
Features 
Description Each handle is designed to fit a specific trephine size.
Info Medtronic Xomed, Inc.
Customer Service: (800) 874-5797
Web site: http://www.xomed.com/

Related medicine products :

1. 7.0mm Calibrated Trephine Handle
2. 7.0mm Notched Trephine Blades
3. Troutman Punch Piston, 5.0 - 7.0mm
4. Castroviejo Corneal Trephine Set
5. Universal Trephine Handle with Cottingham Punch
6. Storz Universal Trephine Handle
7. Michele Vertebral Biopsy Trephine
8. Galt Skull Trephine
9. Disposable Trephine Blade (set of 5)
10. 7.25mm Open Trephine Handle
11. 8.00mm Open Trephine Handle
The RX imola is a bench-top fully automated random access clinical analyser that offers a host of features usually only seen on larger systems. The RX imola has the capacity to perform up to 400 test
Inquire
...is a serum glycoprotein which binds several sex st...pacity, including testosterone and dihydrotestoste...esser extent, estradiol [1]. SHBG specifically bin...e bioavailability of sex steroids. SHBG is produce...
...long to the transforming growth factor- (TGF-) sup... extra-cellular growth factors which control many ...tumor formation (1). Other members incude TGF-s, b... factors, AMH/MIS (Anti-Mullerian Hormone/Mulleria...
Medicine Products:
(Date:9/5/2008)...RNewswire/ -- On Saturday, September 6, PARI,Respi...twork show Today,s,Family as part of their "Breath... medical device company that provides patients, su...d compressors that deliver needed,medications dire... lives of those affected by respiratory,diseases a...
(Date:9/5/2008)...r those overweight or obese at age 45 , ,...of all American adults will develop osteoarthritis... they are obese in middle age, a new study says. ...on increased as his or her body-mass index (BMI) r... at Chapel Hill study. People who were of normal w...
(Date:9/5/2008)...ediction models are enhanced by taking into accoun... capacity, according to research teams led by epid...son Cancer Center in two complementary papers appe... Research . , In the first study to focus on Afr...ased on increased exposure to certain risks. Based...
(Date:9/4/2008)...2008Private Medicare Advantage (MA) plans will be ...2008 compared to what the same enrollee would have...program, according to a new report from The Common... plans mandated by the Medicare Improvements for P...ed to take effect beginning in 2010 had been full...
Breaking Medicine News(10 mins):Health News:PARI Respiratory Equipment Featured on Oxygen Network 2Health News:Almost Half of Adults Will Develop Knee Osteoarthritis by 85 2Health News:Creating lung cancer risk models for specific populations refines prediction 2Health News:Creating lung cancer risk models for specific populations refines prediction 3Health News:Extra payments to Medicare Advantage plans to total $8.5 billion in 2008 2
... they want to investigate the case of a British ma...s, reports BBC. // Two Sunday newspapers report Sc...iagnosed as HIV-positive in 2002, but found to be ...lsea and Westminster Healthcare NHS Trust, which c...
...po and researchers have found that the habit of be...n to families making it a genetic character. Resea...oin a group which has more social character people...in 8,000 pairs of twins and found that 50 percent ...
...hrough, which could eventually lead to a practical...s, scientists from the US National Cancer Institut... human body to produce chemicals that block HIV in...urs on the surfaces of the gut and reproductive ar...
...h Minister Anbumani Ramadoss on Saturday urged the...n and modernisation of the 80-year-old Communicabl...hennai.// After a visit to the cholera wards in t... that though the doctors in the CDH had been succe...
Other Medicine News:Health News:British man 'Recovered from HIV' 2Health News:Genetically modified bacteria to combat HIV 2Health News:Diligence Of Chennai Doctors Appreciated: Anbumani 2
(Date:9/5/2008)...SNewswire/ -- The Florida,Technology, Research and...ic University researcher Dr. Herbert Weissbach, di...or Molecular Biology and,Biotechnology in the Char...es LLC (CHS), $184,294 as part of the State Univer...rogram (SURECAG). SURECAG was,established by the F...
(Date:9/5/2008)...USNewswire/ -- A team of,researchers at West Virgi...,India and Pakistan take on the habits of their ad...cancer among male immigrants and breast cancer,amo...evelop due to many reasons, but,environmental fact...rs,",said Jame Abraham, M.D., medical director for...
(Date:9/4/2008)...FirstCall/ -- BioForm Medical,Inc. (Nasdaq: BFRM... of,Polidocanol, conducted in Germany by BioForm M... GmbH (Kreussler), successfully met the study prim... of a New Drug Application,(NDA) process., In the...and safety of,Aethoxysklerol compared to Sodium Te...
(Date:9/4/2008)...-- Southern Research Institute,today announced tha...cted,the organization to participate in the newly-... Network (MLPCN). The MLPCN -- a collaborative,res...s Program which is,designed to benefit human healt...e and validate future targets for drug discovery.,...
Breaking Medicine Technology:Major State Grant Accelerates Research and Development of Novel Cancer Therapy 2Major State Grant Accelerates Research and Development of Novel Cancer Therapy 3Immigrants From India, Pakistan Face U.S. Prostate, Breast Cancer Risks 2338 Patient Pivotal Trial Demonstrates Safety and Effectiveness of Polidocanol Sclerotherapy Product for Varicose Vein Treatment 2338 Patient Pivotal Trial Demonstrates Safety and Effectiveness of Polidocanol Sclerotherapy Product for Varicose Vein Treatment 3338 Patient Pivotal Trial Demonstrates Safety and Effectiveness of Polidocanol Sclerotherapy Product for Varicose Vein Treatment 4338 Patient Pivotal Trial Demonstrates Safety and Effectiveness of Polidocanol Sclerotherapy Product for Varicose Vein Treatment 5Southern Research Institute Wins $14.7 Million NIH Award to Participate in Molecular Libraries Probe Production Center Network 2Southern Research Institute Wins $14.7 Million NIH Award to Participate in Molecular Libraries Probe Production Center Network 3Southern Research Institute Wins $14.7 Million NIH Award to Participate in Molecular Libraries Probe Production Center Network 4American Elements Announces Expanded Bromide and Iodide Manufacturing Capacity 25672 1Five Steps for Staying in Financial Control with Long Term Disability 25667 1Five Steps for Staying in Financial Control with Long Term Disability 25667 2Five Steps for Staying in Financial Control with Long Term Disability 25667 3Five Steps for Staying in Financial Control with Long Term Disability 25667 4Resverlogix Notice of Conference Call 26 Webcast 7279 1Resverlogix Notice of Conference Call 26 Webcast 7279 2BioMarin Announces Roll Out of National PKU Registry 7278 1BioMarin Announces Roll Out of National PKU Registry 7278 2BioMarin Announces Roll Out of National PKU Registry 7278 3
...hering-Plough Corp. announced results,from a Phase...th,Caelyx (pegylated liposomal doxorubicin hydroch...n (TTP) in patients with,metastatic breast cancer ...fter first-line chemotherapy. These data were pres...ican Society of,Clinical Oncology. , ,"While stand...
...est Ever Phase III Clinical Trial in,Lung Cancer T...FirstCall/ --,GlaxoSmithKline today announced fina...trial of its investigational MAGE-A3,Antigen-Speci...itive patients with stage IB or II Non-Small Cell ...the 2007 American Society of,Clinical Oncology (AS...
Other Medicine Technology:Caelyx Delays Time to Disease Progression as Maintenance Therapy in,Patients with Metastatic Breast Cancer 2Caelyx Delays Time to Disease Progression as Maintenance Therapy in,Patients with Metastatic Breast Cancer 3Caelyx Delays Time to Disease Progression as Maintenance Therapy in,Patients with Metastatic Breast Cancer 4Caelyx Delays Time to Disease Progression as Maintenance Therapy in,Patients with Metastatic Breast Cancer 5Encouraging Clinical Activity of GSK's Novel Cancer,Immunotherapeutic Confirmed in Phase II Study in Patients with Most,Common Form of Lung Cancer 2Encouraging Clinical Activity of GSK's Novel Cancer,Immunotherapeutic Confirmed in Phase II Study in Patients with Most,Common Form of Lung Cancer 3Encouraging Clinical Activity of GSK's Novel Cancer,Immunotherapeutic Confirmed in Phase II Study in Patients with Most,Common Form of Lung Cancer 4Encouraging Clinical Activity of GSK's Novel Cancer,Immunotherapeutic Confirmed in Phase II Study in Patients with Most,Common Form of Lung Cancer 5Encouraging Clinical Activity of GSK's Novel Cancer,Immunotherapeutic Confirmed in Phase II Study in Patients with Most,Common Form of Lung Cancer 6